Celldex Therapeutics Inc logo

Celldex Therapeutics Inc

NAS:CLDX (USA)  
$ 36.56 +1.46 (+4.16%) 11:10 PM EST
P/E:
At Loss
P/B:
5.29
Market Cap:
$ 1.73B
Enterprise V:
$ 1.42B
Volume:
818.76K
Avg Vol (2M):
513.10K
Also Trade In:
Volume:
818.76K
Market Cap $:
1.73B
PE Ratio:
At Loss
Avg Vol (2M):
513.10K
Enterprise Value $:
1.42B
PB Ratio:
5.29

Business Description

Description
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
Name Current Vs Industry Vs History
Cash-To-Debt 75.61
Equity-to-Asset 0.93
Debt-to-Equity 0.01
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 34.02
Distress
Grey
Safe
Beneish M-Score -0.54
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 27.34
9-Day RSI 29.48
14-Day RSI 33.33
6-1 Month Momentum % 43.39
12-1 Month Momentum % 12.51

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 17.07
Quick Ratio 17.07
Cash Ratio 16.39
Days Sales Outstanding 32.46

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -40.6

Financials (Next Earnings Date:2023-05-05 Est.)

CLDX's 30-Y Financials

How Celldex Therapeutics Inc (CLDX) Makes Its Money

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CLDX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Executives

Details

Valuation chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.357
EPS (TTM) ($) -2.39
Beta 1.7
Volatility % 48.77
14-Day RSI 33.33
14-Day ATR ($) 2.274108
20-Day SMA ($) 42.557
12-1 Month Momentum % 12.51
52-Week Range ($) 19.85 - 48.4
Shares Outstanding (Mil) 47.21

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Celldex Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Celldex Therapeutics Inc Stock Events

Event Date Price($)
No Event Data

Celldex Therapeutics Inc Frequently Asked Questions

What is Celldex Therapeutics Inc(CLDX)'s stock price today?
The current price of CLDX is $36.56. The 52 week high of CLDX is $48.40 and 52 week low is $19.85.
When is next earnings date of Celldex Therapeutics Inc(CLDX)?
The next earnings date of Celldex Therapeutics Inc(CLDX) is 2023-05-05 Est..
Does Celldex Therapeutics Inc(CLDX) pay dividends? If so, how much?
Celldex Therapeutics Inc(CLDX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1